Feline Respiratory Infections: Etiology, Zoonotic Risk, and Diagnostic Approach
Introduction
Feline respiratory infections represent a complex disease syndrome with multiple etiological agents, including both viruses and bacteria, that compromise the upper and lower airways of domestic cats. Understanding the etiology, transmission dynamics, and zoonotic potential of these pathogens is essential for veterinary practitioners, diagnosticians, and public health professionals. This article provides an exhaustive review of the biological mechanisms underlying feline respiratory infections, the biophysical principles of host-pathogen interactions, and the rational diagnostic approach to differentiate etiologies. Emphasis is placed on answering three core clinical questions: how do cats get respiratory infections, are cat respiratory infections dangerous, and is cat respiratory infection contagious to humans.
Etiology
Feline respiratory infections are typically polymicrobial, with viral agents acting as primary initiators and bacterial pathogens serving as secondary invaders or coinfecting agents. The major etiological agents include feline herpesvirus type 1 (FHV-1), feline calicivirus (FCV), Bordetella bronchiseptica, and Chlamydia felis [1, 2]. Less common but clinically relevant bacteria include Mycoplasma felis and Streptococcus canis [3].
Viral Pathogens
Feline herpesvirus type 1 (FHV-1) is an enveloped, double-stranded DNA virus belonging to the family Herpesviridae, subfamily Alphaherpesvirinae. The viral capsid is icosahedral, approximately 150–200 nm in diameter, and contains a tegument layer that delivers critical proteins into host cells upon fusion [1]. FHV-1 establishes lifelong latency in trigeminal ganglia after primary infection, and reactivation occurs under stress, immunosuppression, or corticosteroid administration [2]. The virus exhibits tropism for epithelial cells of the conjunctiva, cornea, and upper respiratory mucosa, causing lytic infection and syncytia formation [1, 2].
Feline calicivirus (FCV) is a non-enveloped, single-stranded positive-sense RNA virus belonging to the family Caliciviridae. The capsid is composed of 90 capsomeres arranged in a T=3 icosahedral lattice, with a diameter of approximately 35–40 nm [3]. FCV is antigenically diverse, with multiple strains circulating in cat populations. The virus replicates in the cytoplasm of oropharyngeal and respiratory epithelial cells, inducing vacuolization and cell lysis [3]. A hypervirulent variant, virulent systemic feline calicivirus (VS-FCV), can cause systemic disease with high mortality [4].
Bacterial Pathogens
Bordetella bronchiseptica is a Gram-negative, aerobic, motile coccobacillus that produces a variety of virulence factors, including filamentous hemagglutinin, pertactin, and dermonecrotic toxin [5]. This bacterium colonizes the ciliated respiratory epithelium, where its adhesins mediate attachment, and its toxins disrupt mucociliary clearance [5]. B. bronchiseptica is a primary pathogen in kittens and can act as a co-pathogen in adult cats with viral infections [6].
Chlamydia felis is an obligate intracellular Gram-negative bacterium that infects conjunctival epithelial cells. It possesses a biphasic developmental cycle: elementary bodies (EBs) are the infectious, metabolically inert form, whereas reticulate bodies (RBs) are the replicative intracellular form [7]. The life cycle begins when EBs attach to host cell microvilli and are internalized via endocytosis; within the inclusion, EBs differentiate into RBs, undergo binary fission, and then re-differentiate into EBs for release [7]. C. felis primarily causes conjunctivitis but can also be isolated from the upper respiratory tract [8].
Mycoplasma felis is a cell wall-deficient bacterium that colonizes the mucosal surfaces of the respiratory tract. Its lack of a cell wall renders it resistant to beta-lactam antibiotics and requires specialized culture media [9]. M. felis is often isolated from cats with chronic conjunctivitis and lower respiratory tract disease [9].
Transmission: How Do Cats Get Respiratory Infections?
Transmission of feline respiratory pathogens occurs primarily through direct contact with infected secretions, fomites, and aerosol droplets [1, 2]. The most efficient route is close contact between cats, such as in multi-cat households, shelters, and catteries [3]. The incubation period varies: for FHV-1 it is 2–6 days, for FCV 2–10 days, for B. bronchiseptica 2–7 days, and for C. felis 3–10 days [1, 3, 6].
Direct contact involves exposure to ocular, nasal, or oral secretions from an infected cat. FHV-1 is shed in high titers from the eyes and nose during acute infection and intermittently during reactivation [2]. FCV is shed continuously from the oropharynx and can persist in the environment for up to one month at room temperature [3].
Fomite transmission is particularly relevant for FCV, which is resistant to many disinfectants due to its non-enveloped structure. Contaminated food bowls, bedding, and human hands can transfer FCV to naive cats [3]. B. bronchiseptica can survive in water for several days, allowing indirect transmission via drinking bowls [6].
Aerosol transmission over short distances (less than 1 meter) is significant for FHV-1 and B. bronchiseptica. Sneezing cats generate droplet nuclei that contain infectious particles [5]. In contrast, C. felis is less robust in aerosol transmission and requires close contact for spread [7].
Vertical transmission is not considered a major route, but kittens can become infected shortly after birth through contact with the queen's infected secretions [1].
Clinical Signs: Are Cat Respiratory Infections Dangerous?
The severity of feline respiratory infections depends on the etiological agent, host immune status, age, and presence of coinfections. Most infections are self-limiting in healthy adult cats but can be dangerous in kittens, geriatric cats, and immunosuppressed individuals [1, 2].
FHV-1 causes acute upper respiratory signs: serous ocular and nasal discharge progressing to mucopurulent, conjunctival hyperemia, chemosis, and corneal ulcers. Dendritic ulcers are pathognomonic for FHV-1 keratitis [1]. Severe cases can lead to corneal perforation and panophthalmitis [2]. FHV-1 is particularly dangerous in neonates, causing fatal pneumonia and encephalitis [2].
FCV typically produces oral ulceration (especially on the tongue and hard palate), salivation, and mild upper respiratory signs. Some strains cause lameness (limping kitten syndrome) associated with transient synovitis [3]. VS-FCV strains can cause severe systemic disease with pyrexia, edema, cutaneous ulcers, and mortality rates exceeding 50% in adult cats [4].
B. bronchiseptica infection presents with paroxysmal coughing, sneezing, nasal discharge, and occasionally pneumonia, especially in kittens [6]. The cough is often harsh and can persist for weeks. In severe cases, dyspnea and pulmonary consolidation develop [6].
C. felis predominantly causes conjunctivitis with chemosis, blepharospasm, and serous ocular discharge that becomes purulent over time [8]. Chronic infection can lead to follicular conjunctivitis and corneal neovascularization. Lower respiratory involvement is uncommon but reported [8].
Mixed infections are common and exacerbate clinical severity. FHV-1 and B. bronchiseptica coinfection increases the risk of severe pneumonia [6]. FCV and C. felis together produce more severe conjunctivitis than either alone [8].
In summary, while many feline respiratory infections are mild and self-limiting, they can be dangerous in vulnerable populations. Complications include chronic rhinitis, sinusitis, bronchiectasis, and bacterial pneumonia. Early veterinary intervention reduces morbidity and mortality [1, 2].
Zoonotic Risk: Is Cat Respiratory Infection Contagious to Humans?
The zoonotic potential of feline respiratory pathogens is limited but not negligible. The primary agents with documented human infection are Bordetella bronchiseptica and Chlamydia felis [5, 7]. FHV-1 and FCV are species-specific and do not infect humans.
Bordetella bronchiseptica is a pathogen of multiple mammalian species, including dogs, pigs, and humans. While rare, human infection has been reported in immunocompromised individuals, particularly those with HIV/AIDS, organ transplants, or malignancy [5]. Transmission occurs through direct contact with respiratory secretions from infected cats or dogs. Human cases typically present with pertussis-like illness (paroxysmal cough, post-tussive vomiting) or pneumonia [5]. Healthy adults are generally resistant, but the bacterium can colonize the human respiratory tract asymptomatically.
Chlamydia felis is a close relative of Chlamydia psittaci (the agent of psittacosis) and has been isolated from humans with conjunctivitis and respiratory disease [7]. Human infection is typically acquired through direct conjunctival contact with infected cat ocular secretions. Cases of follicular conjunctivitis in cat owners and veterinary personnel are well documented [7]. The organism can be detected by PCR from human conjunctival swabs. However, transmission is inefficient, and most exposed individuals remain asymptomatic.
General recommendations for immunocompromised cat owners include practicing good hand hygiene, avoiding contact with sick cats, and seeking veterinary care for respiratory signs in their pets. Veterinary staff should use gloves and eye protection when handling cats with respiratory disease [5, 7].
For a broader discussion of zoonotic risk from feline respiratory infections, refer to Feline Upper Respiratory Infections: Zoonotic Potential and Public Health.
Diagnostic Approach
Accurate diagnosis of feline respiratory infections requires a combination of clinical assessment, cytology, molecular detection, and serology. The choice of diagnostic test depends on the suspected etiology, clinical presentation, and available laboratory resources.
Physical Examination and Sample Collection
A thorough ophthalmic examination is critical: conjunctival hyperemia, chemosis, and corneal ulcers suggest FHV-1 or C. felis infection. Oral examination can reveal ulcerative lesions typical of FCV. Auscultation may detect crackles or wheezes indicative of lower airway involvement [1, 2].
Samples should be collected from the conjunctival sac, nasopharynx, or oropharynx using sterile swabs. For FHV-1 and FCV, swabs are placed in viral transport medium. For B. bronchiseptica and C. felis, bacterial transport medium is appropriate. Deep nasal flushing or bronchoalveolar lavage may be necessary for lower respiratory infections [1, 3].
Cytology
Conjunctival cytology using Diff-Quik staining can reveal intracytoplasmic inclusions in epithelial cells, which is suggestive of C. felis infection [7]. Neutrophilic or eosinophilic inflammation may be seen. Gram staining of nasal discharge can identify Gram-negative coccobacilli (B. bronchiseptica) [5].
Molecular Diagnostics
Polymerase chain reaction (PCR) is the gold standard for detecting FHV-1, FCV, B. bronchiseptica, and C. felis due to its high sensitivity and specificity [1, 3]. Real-time PCR (qPCR) allows quantitation of viral load, which can help differentiate active infection from latent shedding in the case of FHV-1 [1]. Conventional PCR with amplicon sequencing can type FCV strains [4].
Multiplex PCR panels that simultaneously detect multiple pathogens are commercially available and are recommended for respiratory disease outbreaks in multi-cat environments. These panels reduce turnaround time and conserve sample volume [3].
Serology
Serology is rarely used for acute diagnosis due to the prevalence of antibodies in vaccinated cats and the time required for seroconversion. However, paired serology showing a fourfold rise in antibody titers can confirm recent FHV-1 or FCV infection [1]. C. felis serology by ELISA detects anti-Chlamydia antibodies, but cross-reaction with other chlamydiae limits specificity [7].
Bacterial Culture
Bacterial culture for B. bronchiseptica and C. felis requires specific media. B. bronchiseptica grows on MacConkey agar and Bordet-Gengou agar within 48 hours [5]. C. felis requires cell culture (e.g., McCoy cells) because it is an obligate intracellular organism; detection takes 3–7 days [7]. Culture is less sensitive than PCR and is usually reserved for antimicrobial susceptibility testing in refractory cases.
Diagnostic Decision Tree
The following Mermaid diagram outlines a rational diagnostic workflow for feline respiratory infections:
graph TD
A[Cat with respiratory signs], > B{Corneal ulcer or dendritic lesion?}
B, >|Yes| C[PCR for FHV-1]
B, >|No| D{Oral ulcer or lameness?}
D, >|Yes| E[PCR for FCV]
D, >|No| F{Conjunctivitis predominant?}
F, >|Yes| G[PCR for C. felis + FHV-1]
F, >|No| H{Cough prominent?}
H, >|Yes| I[Bacterial culture + PCR for Bordetella]
H, >|No| J[Multiplex PCR panel]
C, > K[Antiviral therapy if FHV-1 positive]
G, > L[Treatment based on detected pathogen]
I, > M[Antimicrobial therapy based on culture]
J, > N[Direct treatment per multiplex results]
This algorithm hinges on distinct clinical presentations to prioritize testing and reduce costs, while recommending broad multiplex panels for mixed-sign cases.
Advanced Diagnostics
For chronic or refractory cases, advanced imaging (computed tomography of nasal passages) can reveal turbinate destruction or nasopharyngeal polyps secondary to chronic rhinitis [2]. Histopathology of nasal biopsy samples can identify chronic inflammatory changes, but it is rarely performed for infectious diagnosis alone.
Treatment and Control
Treatment strategies target the specific agent or combination of agents identified. Antiviral therapy for FHV-1 includes topical cidofovir or famciclovir systemic administration [1]. FCV has no specific antiviral; supportive care and fluid therapy are the mainstays. Bacterial infections are treated with appropriate antimicrobials: doxycycline is first-line for C. felis and M. felis, and both B. bronchiseptica and C. felis respond to tetracyclines [5, 7].
Vaccination against FHV-1, FCV, and C. felis is a cornerstone of control. Modified-live and inactivated vaccines reduce clinical severity, but do not prevent infection or shedding [1, 2]. Environmental disinfection must use agents effective against non-enveloped viruses (e.g., bleach 1:32 dilution for FCV) and against bacteria (e.g., quaternary ammonium compounds) [3].
For additional information on bacterial pathogens and management strategies, see Cat Bacterial Respiratory Infections: Etiology, Clinical Presentation, and Diagnostic Approaches and Feline Bacterial Respiratory Infections: Etiology and Management.
Conclusions
Feline respiratory infections are multifactorial diseases with viral and bacterial components. Transmission occurs through direct contact, fomites, and aerosols. While most infections are self-limiting, they can be dangerous in young, old, or immunosuppressed cats. Zoonotic transmission of B. bronchiseptica and C. felis to immunocompromised humans is documented, underscoring the need for biosecurity in veterinary settings. Diagnosis relies heavily on PCR-based methods, with clinical algorithms guiding test selection. Appropriate treatment and vaccination reduce morbidity and shedding. Integrated diagnostic approaches that combine clinical evaluation, molecular detection, and antimicrobial susceptibility testing optimize outcomes.
References
[1] Greene CE. Infectious Diseases of the Dog and Cat. 4th ed. St. Louis: Elsevier Saunders; 2012.
[2] Gaskell R, Dawson S, Radford A. Feline respiratory disease. In: Greene CE, editor. Infectious Diseases of the Dog and Cat. 4th ed. St. Louis: Elsevier Saunders; 2012. p. 131-151.
[3] Radford AD, Coyne KP, Dawson S, et al. Feline calicivirus. Vet Res. 2007;38(2):319-335.
[4] Hurley KF, Pesavento PA, Pedersen NC, et al. An outbreak of virulent systemic feline calicivirus disease. J Am Vet Med Assoc. 2003;223(10):1463-1470.
[5] Egberink H, Addie D, Belák S, et al. Bordetella bronchiseptica infection in cats. J Feline Med Surg. 2009;11(6):463-473.
[6] Foley JE, Rand C, Bannasch MJ, et al. Molecular epidemiology of feline bordetellosis in two animal shelters in California, USA. Prev Vet Med. 2002;54(2):141-156.
[7] Sykes JE. Feline chlamydiosis. Clin Tech Small Anim Pract. 2005;20(3):170-175.
[8] Wills J, Howard P, Gruffydd-Jones TJ, et al. Prevalence of Chlamydia psittaci in different cat populations in Britain. J Small Anim Pract. 1988;29(7):387-394.
[9] Lappin MR. Mycoplasma infections. In: Greene CE, editor. Infectious Diseases of the Dog and Cat. 4th ed. St. Louis: Elsevier Saunders; 2012. p. 426-431. *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.